flecainide has been researched along with Acute Disease in 18 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether an oral loading dose of flecainide is as safe and effective as intravenous flecainide for the cardioversion of acute atrial fibrillation." | 9.09 | Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. ( Alp, NJ; Bell, JA; Shahi, M, 2000) |
| "Evaluation of efficacy of intravenous flecainide to revert supraventricular arrhythmias to sinus rhythm in patients with respiratory insufficiency." | 9.07 | Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency. ( Barranco, F; Guerrero, M; Rodriguez, J; Sanchez, M, 1994) |
| "The efficacy and safety of intravenous flecainide to convert recent-onset atrial fibrillation (AF) (present for greater than or equal to 30 minutes and less than or equal to 72 hours and a ventricular response greater than or equal to 120 beats/min) was investigated." | 9.07 | Efficacy of flecainide for the reversion of acute onset atrial fibrillation. ( Clarke, GM; Coombs, LJ; Dobb, GJ; Donovan, KD; Lee, KY; Murdock, CJ; Weekes, JN, 1992) |
| " flecainide has a high efficacy for the treatment of experimentally-induced acute atrial fibrillation (AF) in horses and that its use is associated with minimal toxic side effects." | 7.72 | Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation. ( Blissitt, KJ; Keen, JA; van Loon, G; Young, LE, 2004) |
| "Flecainide was as effective as the combination of digoxin and disopyramide and it acted significantly faster and was associated with fewer relapses." | 6.66 | Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass. ( Campbell, TJ; Gavaghan, TP; Kelly, RP; Koegh, AM; Morgan, JJ; Thorburn, C, 1988) |
| "Flecainide is a rare cause of hypersensitivity pneumonitis, and few cases have been reported." | 6.41 | Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome. ( Fuhrman, C; Perchet, H; Robain, A, 2000) |
| "Patients received intravenous flecainide, propafenone, or amiodarone on presentation and a second dose after 6 hours if atrial fibrillation persisted." | 5.14 | Management of patients with acute atrial fibrillation in the ED. ( Abbate, R; Conti, A; Del Taglia, B; Gensini, GF; Grifoni, S; Mariannini, Y; Michelucci, A; Padeletti, L; Pepe, G; Vanni, S, 2010) |
| "To investigate whether an oral loading dose of flecainide is as safe and effective as intravenous flecainide for the cardioversion of acute atrial fibrillation." | 5.09 | Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. ( Alp, NJ; Bell, JA; Shahi, M, 2000) |
| "Evaluation of efficacy of intravenous flecainide to revert supraventricular arrhythmias to sinus rhythm in patients with respiratory insufficiency." | 5.07 | Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency. ( Barranco, F; Guerrero, M; Rodriguez, J; Sanchez, M, 1994) |
| "The efficacy and safety of intravenous flecainide to convert recent-onset atrial fibrillation (AF) (present for greater than or equal to 30 minutes and less than or equal to 72 hours and a ventricular response greater than or equal to 120 beats/min) was investigated." | 5.07 | Efficacy of flecainide for the reversion of acute onset atrial fibrillation. ( Clarke, GM; Coombs, LJ; Dobb, GJ; Donovan, KD; Lee, KY; Murdock, CJ; Weekes, JN, 1992) |
| " flecainide has a high efficacy for the treatment of experimentally-induced acute atrial fibrillation (AF) in horses and that its use is associated with minimal toxic side effects." | 3.72 | Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation. ( Blissitt, KJ; Keen, JA; van Loon, G; Young, LE, 2004) |
| "Plasma flecainide (FLC) levels versus time were measured in a group of 10 acute myocardial infarction (AMI) patients at our Intensive Care Unit." | 3.67 | Clinical pharmacokinetics of intravenous flecainide in critically ill patients. ( Ibáñez, P; Rodriguez, M; Sánchez-Alcaraz, A; Sangrador, G, 1989) |
| "Flecainide was as effective as the combination of digoxin and disopyramide and it acted significantly faster and was associated with fewer relapses." | 2.66 | Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass. ( Campbell, TJ; Gavaghan, TP; Kelly, RP; Koegh, AM; Morgan, JJ; Thorburn, C, 1988) |
| "Flecainide is a rare cause of hypersensitivity pneumonitis, and few cases have been reported." | 2.41 | Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome. ( Fuhrman, C; Perchet, H; Robain, A, 2000) |
| " Adverse effects were associated with larger dosage and atrial flutter or atrial reentrant tachycardia." | 1.27 | Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm. ( Crozier, IG; Ikram, H; Kenealy, M; Levy, L, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, JJ | 1 |
| Ramazan, L | 1 |
| Bockemeyer, C | 1 |
| Günter, HH | 1 |
| Martens-Lobenhoffer, J | 1 |
| Ganzenmüller, T | 1 |
| Bode-Böger, SM | 1 |
| Kielstein, JT | 1 |
| Hirschl, MM | 1 |
| Wollmann, C | 1 |
| Globits, S | 1 |
| Conti, A | 1 |
| Del Taglia, B | 1 |
| Mariannini, Y | 1 |
| Pepe, G | 1 |
| Vanni, S | 1 |
| Grifoni, S | 1 |
| Abbate, R | 1 |
| Michelucci, A | 1 |
| Padeletti, L | 1 |
| Gensini, GF | 1 |
| Muñoz Bono, J | 1 |
| Curiel Balsera, E | 1 |
| Cabrera Calandria, A | 1 |
| Jiménez Pérez, G | 1 |
| van Loon, G | 1 |
| Blissitt, KJ | 1 |
| Keen, JA | 1 |
| Young, LE | 1 |
| Aliot, E | 1 |
| Baille, N | 1 |
| Zannad, F | 1 |
| Gilgenkrantz, JM | 1 |
| Thale, J | 1 |
| Gülker, H | 1 |
| Bender, F | 1 |
| Heuer, H | 1 |
| Kristek, J | 1 |
| Schindelhauer, F | 1 |
| Hübner, G | 1 |
| Barranco, F | 1 |
| Sanchez, M | 1 |
| Rodriguez, J | 1 |
| Guerrero, M | 1 |
| Mannino, MM | 1 |
| Mehta, D | 1 |
| Gomes, JA | 1 |
| Oltrona, L | 1 |
| Broccolino, M | 1 |
| Merlini, PA | 1 |
| Spinola, A | 1 |
| Pezzano, A | 1 |
| Mannucci, PM | 1 |
| Robain, A | 1 |
| Perchet, H | 1 |
| Fuhrman, C | 1 |
| Alp, NJ | 1 |
| Bell, JA | 1 |
| Shahi, M | 1 |
| Antonelli, D | 1 |
| Freedberg, NA | 1 |
| Rosenfeld, T | 1 |
| Donovan, KD | 1 |
| Dobb, GJ | 1 |
| Coombs, LJ | 1 |
| Lee, KY | 1 |
| Weekes, JN | 1 |
| Murdock, CJ | 1 |
| Clarke, GM | 1 |
| Hanston, P | 1 |
| Evrard, P | 1 |
| Mahieu, P | 1 |
| Wallemacq, P | 1 |
| Friob, M | 1 |
| Hassoun, A | 1 |
| Sangrador, G | 1 |
| Sánchez-Alcaraz, A | 1 |
| Rodriguez, M | 1 |
| Ibáñez, P | 1 |
| Crozier, IG | 1 |
| Ikram, H | 1 |
| Kenealy, M | 1 |
| Levy, L | 1 |
| Gavaghan, TP | 1 |
| Koegh, AM | 1 |
| Kelly, RP | 1 |
| Campbell, TJ | 1 |
| Thorburn, C | 1 |
| Morgan, JJ | 1 |
1 review available for flecainide and Acute Disease
| Article | Year |
|---|---|
Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome.
Topics: Abnormalities, Multiple; Acute Disease; Anti-Arrhythmia Agents; Flecainide; Heart Defects, Congenita | 2000 |
5 trials available for flecainide and Acute Disease
| Article | Year |
|---|---|
Management of patients with acute atrial fibrillation in the ED.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; | 2010 |
Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency.
Topics: Acute Disease; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Chi-Square Distribution; Electrocardio | 1994 |
Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation.
Topics: Acute Disease; Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distrib | 2000 |
Efficacy of flecainide for the reversion of acute onset atrial fibrillation.
Topics: Acute Disease; Arrhythmias, Cardiac; Atrial Fibrillation; Digoxin; Double-Blind Method; Drug Evaluat | 1992 |
Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass.
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Clin | 1988 |
12 other studies available for flecainide and Acute Disease
| Article | Year |
|---|---|
Acute interstitial nephritis due to flecainide therapy in the 38(th) week of pregnancy.
Topics: Acute Disease; Acute Kidney Injury; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; | 2016 |
A 2-year survey of treatment of acute atrial fibrillation in an ED.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillati | 2011 |
[Severe acute flecainide intoxication].
Topics: Acute Disease; Adolescent; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Severity of Illness I | 2012 |
Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation.
Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Chronic D | 2004 |
[Effect of intravenous flecainide in the treatment of acute ventricular arrhythmia].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiog | 1983 |
[Anti-arrhythmia effect of flecainide in acute myocardial infarct in comparison with lidocaine].
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Dogs; Flecainide; Lidocaine; Myocardial Infarction; Pi | 1981 |
Current treatment options for paroxysmal supraventricular tachycardia.
Topics: Acute Disease; Catheter Ablation; Chronic Disease; Flecainide; Humans; Propafenone; Tachycardia, Atr | 1994 |
Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Antithrombin III; Atrial Fibrillation; Biomarkers | 1997 |
Acute loss of capture due to flecainide acetate.
Topics: Acute Disease; Aged; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Pacemaker, Artificial; Pros | 2001 |
Flecainide-associated interstitial pneumonitis.
Topics: Acute Disease; Arrhythmias, Cardiac; Flecainide; Humans; Male; Middle Aged; Pulmonary Fibrosis; Resp | 1991 |
Clinical pharmacokinetics of intravenous flecainide in critically ill patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Flecainide; Half-Life; Humans; Injections, Intraveno | 1989 |
Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
Topics: Acute Disease; Adolescent; Adult; Aged; Female; Flecainide; Heart Rate; Humans; Infusions, Intraveno | 1987 |